Repatha (evolocumab)

What is evolocumab?

  • Repatha is used along with diet, exercise and maximum tolerated doses of statins to reduce LDL cholesterol in adults with heterozygous familial hypercholesterolemia (and inherited disorder that causes high levels of LDL) or adults with heart problems related to excess cholesterol in the body.
  • Repatha is also used along with diet and other LDL-lowering treatments, for example, statins, ezetimibe (Zetia) and LDL apheresis, to reduce cholesterol in people with homozygous familial hypercholesterolemia (an inherited disorder that causes high levels of LDL).

What brand names are available for evolocumab?

Repatha

Is evolocumab available as a generic drug?

No

Do I need a prescription for evolocumab?

Yes

What are the side effects of evolocumab?

The most common side effects associated with Repatha treatment include

Other side effects include

A more serious side effect is:

  • Hypersensitivity reactions: Repatha should not be used in patients with a history of serious hypersensitivity reactions to the product. Hypersensitivity reactions include itching, rash, and hives, have occurred. Repatha should be discontinued if signs or symptoms of serious allergic reactions occur.

QUESTION

In the U.S., 1 in every 4 deaths is caused by heart disease. See Answer

What is the dosage for evolocumab?

  • The recommended subcutaneous dose for patients with heterozygous familial hypercholesterolemia or adults with heart problems related to excess cholesterol in the body is either 140 mg every 2 weeks or 420 mg once monthly.
  • The recommended subcutaneous dosage in patients with homozygous familial hypercholesterolemia is 420 mg once monthly. LDL cholesterol levels should be measured 4 to 8 weeks after starting Repatha since response to therapy will depend on the degree of LDL-receptor function.
  • LDL cholesterol levels should be measured within 4 to 8 weeks of starting therapy to assess response to treatment, and a decision should be made whether or not to adjust the dose.
  • Repatha should only be injected subcutaneously into the thigh, abdomen, or upper arm. Injection sites should be rotated among different sites to prevent or reduce injection site reactions and irritation. Repatha should not be co-administered with other injectable drugs at the same injection site.

Which drugs or supplements interact with evolocumab?

No clinically significant drug-drug interactions are known for Repatha.

Is evolocumab safe to take if I'm pregnant or breastfeeding?

  • There is no data on the use of Repatha in pregnant women.
  • It is not known if Repatha is secreted in human milk or whether it can cause harm to the nursing infant.

What else should I know about evolocumab?

What preparations of evolocumab are available?

Single-use pre-filled syringe and single-use pre-filled Sureclick autoinjector, each designed to deliver 1 ml of 140 mg/ml solution.

How should I keep evolocumab stored?

Repatha should be stored in the refrigerator at 2 C to 8 C (36 F to 46 F) and protected from light. It should not be frozen.

Summary

Repatha (evolocumab) is a drug that belongs to the drug class called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. Repatha is prescribed to reduce LDL cholesterol in adults with heterozygous or homozygous familial hypercholesterolemia or adults with heart problems related to excess cholesterol in the body. Common side effects of Repatha include fatigue, headache, nausea, dizziness, flu- or cold-like symptoms. Drug interactions, dosing, storage, and pregnancy and breastfeeding information should be reviewed before taking this medication.

Treatment & Diagnosis

Medications & Supplements

Prevention & Wellness

Subscribe to MedicineNet's Heart Health Newsletter

By clicking "Submit," I agree to the MedicineNet Terms and Conditions and Privacy Policy. I also agree to receive emails from MedicineNet and I understand that I may opt out of MedicineNet subscriptions at any time.

Health Solutions From Our Sponsors

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

References
FDA Prescribing Information.